Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Sept 2026 for Krystal Biotech, Inc., €8.0M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Suma Krishnan: trading record in brief
Suma Krishnan discloses dealings in Krystal Biotech, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 4 June 2026 to 4 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 4 September 2026 came the latest disclosure, a transaction for €8.0M in Krystal Biotech, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Suma Krishnan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
25,000 shares@ US$371.47CommonSEC144:0001950047-26-009149
25,000 shares@ US$301.820.069% mcap100.0% of flowCommonSEC144:0001950047-26-005653
2 of 2 declarations
